|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
Leveraging Social Media in Pharma: The Hidden Message from the Masses
Social media poses a unique set of challenges to the drug industry — from identification of adverse events to FDA restrictions on marketing.
The billions of conversations taking place on social media provide drug companies with a big opportunity to leverage their data and metadata. To turn this data into useful information for decision-making, strategies and processes need to be developed.
Social media experts — John MacDonald and Phil Baumann — of C3i Healthcare discuss how to best use social media. They will focus on the following:
The conversations are happening and it’s time to capture them and use them to your advantage. Order Leveraging Social Media in Pharma today.
Meet Your Presenters
John MacDaniel, Sr. Director VOC/Digital, C3i Healthcare, a Division of Telerx
John MacDaniel has 25+ years of experience in the contract center industry. His background includes contact center operations, training, quality and customer experience. Since 2008, John has focused on social media, with a bent on defining and expanding the contact center's role in supporting brand social media initiatives.
Phil Baumann, Social Media Strategist, C3i Healthcare, a Division of Telerx
Phil Baumann is Social Media Strategist at C3i Healthcare Connections. A registered nurse with a diverse background in regulated industries, Phil brings an unique set of experiences to implementing digital solutions for clients facing regulatory challenges. He was a founding member of the external advisory board for the Mayo Clinic Center for Social Media. He also started the first clinical Twitter chats, MDchat and RNchat, which have since inspired hundreds of other Healthcare-related discussions on social media.
Copyright ©2017. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing